Mirae Asset Healthcare Fund - Regular Plan - Growth

Equity Create Wealth
Sectoral Fund - Pharma & Health Care
Category Rank
Mirae Asset Healthcare Fund - Regular Plan - Growth
Rating
Fund
Time to Invest
Mirae Asset Healthcare Fund - Regular Plan - Growth
NAV
20.404
(25/05/2022)
L 52Wk H
20.08
24.16
Login using to know what your Friends are Investing !

Mirae Asset Healthcare Fund - Regular Plan - Growth

Equity
Sectoral Fund - Pharma & Health Care
Create Wealth
Rank Mirae Asset Healthcare Fund - Regular Plan - Growth
Fund
NAV
20.404
(25/05/2022)
Time to Invest
Mirae Asset Healthcare Fund - Regular Plan - Growth
Rating
L 52Wk H
20.08
24.16

Asset Allocation for Mirae Asset Healthcare Fund - Regular Plan - Growth Fund Growth

Top 10 Holdings of Mirae Asset Healthcare Fund - Regular Plan - Growth Fund Growth

66.92 % of total assets
Sun Pharmaceutical Industries LimitedSun Pharmaceutical Industries Limited(15.68%)
Dr. Reddy's Laboratories LimitedDr. Reddy's Laboratories Limited(9.18%)
Cipla LimitedCipla Limited(7.91%)
Apollo Hospitals Enterprise LimitedApollo Hospitals Enterprise Limited(7.34%)
Torrent Pharmaceuticals LimitedTorrent Pharmaceuticals Limited(5.40%)
IPCA Laboratories LimitedIPCA Laboratories Limited(5.23%)
Fortis Healthcare LimitedFortis Healthcare Limited(4.50%)
Divi's Laboratories LimitedDivi's Laboratories Limited(4.18%)
Aurobindo Pharma LimitedAurobindo Pharma Limited(3.95%)
Gland Pharma LimitedGland Pharma Limited(3.56%)

Detailed Portfolio of Mirae Asset Healthcare Fund - Regular Plan - Growth Fund Growth

Portfolio Date -31 Mar 2022
Equity Holdings -28
Other Holdings -3
Holdings % Weight Value Sahi Hai/Nahi
Sun Pharmaceutical Industries Limited 15.68% 284.974 Cr
Dr. Reddy's Laboratories Limited 9.18% 166.812 Cr
Cipla Limited 7.91% 143.678 Cr
Apollo Hospitals Enterprise Limited 7.34% 133.306 Cr
Torrent Pharmaceuticals Limited 5.40% 98.050 Cr
IPCA Laboratories Limited 5.23% 95.031 Cr -
Fortis Healthcare Limited 4.50% 81.762 Cr
Divi's Laboratories Limited 4.18% 76.007 Cr
Aurobindo Pharma Limited 3.95% 71.837 Cr
Gland Pharma Limited 3.56% 64.732 Cr
Krishna Institute Of Medical Sciences Limited 3.42% 62.234 Cr -
JB Chemicals & Pharmaceuticals Limited 3.16% 57.413 Cr
Ajanta Pharma Limited 3.14% 56.991 Cr
Lupin Limited 3.05% 55.417 Cr
Natco Pharma Limited 2.49% 45.207 Cr
Alkem Laboratories Limited 2.32% 42.195 Cr
Vinati Organics Limited 2.09% 37.994 Cr
Laurus Labs Limited 2.02% 36.626 Cr
Biocon Limited 1.88% 34.177 Cr
Tatva Chintan Pharma Chem Limited 1.85% 33.641 Cr -
ICICI Lombard General Insurance Company Limited 1.74% 31.644 Cr
Tarsons Products Limited 1.49% 27.150 Cr -
SBI Life Insurance Company Limited 1.36% 24.694 Cr
Max Financial Services Limited 1.25% 22.763 Cr
Dr. Lal Path Labs Limited 1.25% 22.665 Cr
Syngene International Limited 0.51% 9.294 Cr
Abbott India Limited 0.00% 0.004 Cr
Sanofi India Limited 0.00% 0.001 Cr
Holdings % Weight Value Sahi Hai/Nahi
Triparty Repo 0.41% 7.430 Cr -
Mirae Asset Cash Management Fund - DIRECT GROWTH 0.01% 0.183 Cr -
Net Receivables / (Payables) -0.35% -6.443 Cr -

Insight on the composition of the Mirae Asset Healthcare Fund - Regular Plan - Growth Fund Growth

Mirae Asset Healthcare Fund - Regular Plan - Growth

Style Box of the Mirae Asset Healthcare Fund - Regular Plan - Growth Fund Growth

Mirae Asset Healthcare Fund - Regular Plan - Growth

Portfolio Characteristics of the Mirae Asset Healthcare Fund - Regular Plan - Growth Fund Growth

Mirae Asset Healthcare Fund - Regular Plan - Growth